Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal

International Journal of Antimicrobial Agents

Volumn 20, Issue 5, 2002, Pages 339-347

  Dromigny, J A ^a   Nabeth, P ^a   Perrier Gros Claude, J D ^a  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

Antibiotic resistance; Senegal; Urinary tract infection

Indexed keywords

BETA LACTAMASE; CYCLOSPORIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROBACTERIACEAE; FEMALE; GEOGRAPHIC PATHOLOGY; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION SENSITIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SENEGAL; URINARY TRACT INFECTION; ADOLESCENT; CHILD; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; INFANT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; URINARY TRACT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; SENEGAL; URINARY TRACT; URINARY TRACT INFECTIONS;

EID: 0036846826     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00196-6     Document Type: Article

References (22)

1. Gales A.C., Jones R.N., Gordon K.A., et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of SENTRY Antimicrobial Surveillance Program (1998). J. Antimicrob. Chemother. 45:2000;295-303.
2. Bosu W.K., Acquah S. Susceptibility of urinary tract to antibiotics in Cape Coast, Ghana. East Afr. Med. J. 73:1996;468-470.
3. Malonza I.M., Omari M.A., Bwayo J.J., et al. Community acquired bacterial infections and their antimicrobial susceptibility in Nairobi, Kenya. East Afr. Med. J. 74:1997;166-170.
4. Obi C.L., Tarupiwa A., Simango C. Scope of urinary pathogens isolated in the Public Health Bacteriology Laboratory, Harara: antibiotic susceptibility patterns of isolates and incidence of haemolytic bacteria. Cent. Afr. J. Med. 42:1996;244-249.
5. Ako-Nai A.K., Kassim O.O., Adeniran M.O., Taiwo O. A study of urinary tract infections at Ile-Ife, Nigeria. East Afr. Med. J. 70:1993;10-14.
6. Diadhiou F., Mboup S., Koly F., Boye C.S., Moreau J.C. Les infections urinaires en pratique gynéco-obstétricale au CHU de Dakar. Dakar Méd. 35:1990;1-9.
7. Sow A.I., Ndiaye L., Cisse M.F., Gaye-Diallo A., Boye C.S., Samb A. Bactériologie des urines chez le sujet âgé en zone tropicale: Bilan de cinq années d'activités au CHU de Fann à Dakar. Dakar Méd. 38:1993;7-10.
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 1998. Pathol. Biol. 1998;46:I-XVI.
9. Barnett B.J., Stephens D.S. Urinary tract infection: an overview. Am. J. Med. Sci. 314:1997;245-249.
10. Goldstein F.W. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur. J. Clin. Microbiol. Infect. Dis. 19:2000;112-117.
11. Chomarat M. Resistance of bacteria in urinary tract infections. Int. J. Antimicrob. Agents. 16:2000;483-487.
12. Barrett S.P., Savage M.A., Rebec M.P., Guyot A., Andrews N., Shrimpton S.B. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J. Antimicrob. Chemother. 44:1999;359-365.
13. Weber G., Riesenberg K., Schlaeffer F., Peled N., Borer A., Yagupsky P. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatients clinics and a hospital in Southern Israel, 1991-1995. Eur. J. Clin. Microbiol. Infect. Dis. 16:1997;834-838.
14. The SENTRY surveillance Group, North America, Jones R.N., Kugler K.C., Pfaller M.A., Winokur P.L. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 35:1999;55-63.
15. Grüneberg R.N. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J. Antimicrob. Chemother. 33:(Suppl. A):1994;1-8.
16. Winstanley T.G., Limb D.I., Eggington R., Hancock F. A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: The Microbe Base Project. J. Antimicrob. Chemother. 40:1997;591-594.
17. De Mouy D., Cavallo J.D., Fabre R., Grobost F. Armengaud M et les membres de l'AFORCOPIBIO, Les entérobactéries isolées d'infections urinaires en pratique de ville: étude AFORCOPIBIO 1995. BEH. 28:1996;123-124.
18. Weber Ph., Plaisance J.J., Mancy C. Epidémiologie comparée de la résistance aux fluoroquinolones chez les Enterobacteriaceae, Staphylococcus et Pseudomonas aeruginosa en médecine de ville. Presse. Méd. 24:1995;979-982.
19. De Mouy D., Berges J.L., Bouilloux J.P., et al. Sensibilité à la fosfomycine des principales bactéries issues d'infections urinaires observées en pratique de ville chez les femmes de 15 à 65 ans. Méd. Mal. Infect. 27:1997;903-906.
20. Acar J.F., Golstein F.W. Trends in bacterial resistance to fluoroquinolones. Clin. Infect. Dis. 24:(Suppl.1):1997;67-73.
21. Cormican M., Morris D., Corbett-Feeney G., Flynn J. Extended Spectrum Beta-Lactamase production and fluoroquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn. Microbiol. Infect. Dis. 32:1998;317-319.
22. The Vigil Roc Study Group, Goldstein F.W., Péan Y., Gertner J. Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community. Antimicrob. Agents Chemother. 39:1995;12516-12519.